Search research articles
Contact Us
Filters
Showing results (1431-1440 of 1,464) with videos related to
Page
of 147
Sort By:
Journal of Surgical Education
|
November 30, 2023
Predictors of Ophthalmology Resident Performance From Medical Student Application Materials
Andrea A Tooley, Janice Law, Gary J Lelli, et al.
Nature Communications
|
May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors
Stephen Brand, Laura A T Cleghorn, Stuart P McElroy, et al.
The Lancet. Oncology
|
May 15, 2021
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Evan Y Yu, Daniel P Petrylak, Peter H O'Donnell, et al.
Open Forum Infectious Diseases
|
February 12, 2021
Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University Hospital
Krista R Wigginton, Peter J Arts, Herek L Clack, et al.
Nature Communications
|
November 5, 2025
Conformational dynamics, RNA binding, and phase separation regulate the multifunctionality of rabies virus P protein
Stephen M Rawlinson, Shatabdi Chakraborty, Ashish Sethi, et al.
Geroscience
|
March 4, 2025
Rationale and design of the Dog Aging Project precision cohort: a multi-omic resource for longitudinal research in geroscience
Jena Prescott, Amber J Keyser, Paul Litwin, et al.
Journal of Medicinal Chemistry
|
November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis
Stephen Brand, Neil R Norcross, Stephen Thompson, et al.
Cancer
|
August 7, 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer
Tian Zhang, Michael R Harrison, Peter H O'Donnell, et al.
Clinical Genitourinary Cancer
|
August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.
Page
of 147
Search research articles
Search
Showing results (1431-1440 of 1,464) with videos related to
Sort By:
Page
of 147
Journal of Surgical Education
|
November 30, 2023
Predictors of Ophthalmology Resident Performance From Medical Student Application Materials
Andrea A Tooley, Janice Law, Gary J Lelli, et al.
Nature Communications
|
May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors
Stephen Brand, Laura A T Cleghorn, Stuart P McElroy, et al.
The Lancet. Oncology
|
May 15, 2021
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Evan Y Yu, Daniel P Petrylak, Peter H O'Donnell, et al.
Open Forum Infectious Diseases
|
February 12, 2021
Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University Hospital
Krista R Wigginton, Peter J Arts, Herek L Clack, et al.
Nature Communications
|
November 5, 2025
Conformational dynamics, RNA binding, and phase separation regulate the multifunctionality of rabies virus P protein
Stephen M Rawlinson, Shatabdi Chakraborty, Ashish Sethi, et al.
Geroscience
|
March 4, 2025
Rationale and design of the Dog Aging Project precision cohort: a multi-omic resource for longitudinal research in geroscience
Jena Prescott, Amber J Keyser, Paul Litwin, et al.
Journal of Medicinal Chemistry
|
November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis
Stephen Brand, Neil R Norcross, Stephen Thompson, et al.
Cancer
|
August 7, 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer
Tian Zhang, Michael R Harrison, Peter H O'Donnell, et al.
Clinical Genitourinary Cancer
|
August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.
Page
of 147